Post mortem (PM) brain samples have identified PFK activity to be elevated in the temporal and frontal lobes of patients with sporadic AD [22], and potentially these changes in PFK function occur in glial cells, as PFK enzyme colocalizes with glial fibrillary acidic protein (GFAP) [23]. Here, GFAP is linked to Alzheimer disease.